SHERMAN JEFFREY W — SEC insider filings
SEC reporting owner CIK 1230482. 42 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 42 filings on record, filed 2020-10-21 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 13,689 shares, $45,156 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 15 legs across 8 filings — 334,705 shares, $27,637,774 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 121.
- Largest priced transaction: sale of 54,789 shares @ $95.00 ($5,205,097) in Horizon Therapeutics Public Ltd Co, filed 2021-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co (HZNP) | EVP and Chief Medical Officer | 22 | — | 14 legs · 292,473 sh · $27,303,259 | 91 |
| Xeris Biopharma Holdings, Inc. (XERS) | Director | 8 | 1 leg · 5,400 sh · $10,098 | 1 leg · 42,232 sh · $334,515 | 16 |
| Larimar Therapeutics, Inc. (LRMR) | Director | 6 | 2 legs · 8,289 sh · $35,058 | — | 4 |
| Strongbridge Biopharma plc (SBBP) | Director | 4 | — | — | 5 |
| XERIS PHARMACEUTICALS INC (XERS) | Director | 2 | — | — | 5 |
Insider filings — SHERMAN JEFFREY W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 3,289.47 @ $3.06 | EDGAR |
| 2026-05-20 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 5,000 @ $5 | EDGAR |
| 2025-08-29 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Option exercise (M): 47,040 @ $6.66 · Sale (S): 42,232 @ $7.92 · Option exercise (M): 47,040 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-05-14 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-31 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-04-11 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Other (J): 6,502 | EDGAR |
| 2023-11-29 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Purchase (P): 5,400 @ $1.87 | EDGAR |
| 2023-10-06 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Disposition to issuer (D): 2,655 @ $116.50 · Disposition to issuer (D): 105,808 @ $116.50 · Disposition to issuer (D): 80,944 @ $116.50 · Disposition to issuer (D): 45,352 @ $116.50 · Disposition to issuer (D): 164,469 (derivative) · Disposition to issuer (D): 9,314 (derivative) · +11 more | EDGAR |
| 2023-10-05 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 16,600 (derivative) @ $0 | EDGAR |
| 2023-09-07 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 2,165 @ $0 | EDGAR |
| 2023-06-07 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 42,500 @ $0 | EDGAR |
| 2023-01-18 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 33,795 @ $0 · Gift (G): 33,795 @ $0 | EDGAR |
| 2023-01-12 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Sale (S): 3,368 @ $113.05 · Sale (S): 3,368 @ $113.10 | EDGAR |
| 2023-01-06 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 51,132 · Tax withholding (F): 22,655 @ $113.24 · Sale (S): 5,187 @ $113.29 · Grant/award (A): 18,397 (derivative) @ $0 · Option exercise (M): 12,095 (derivative) @ $0 · Option exercise (M): 9,314 (derivative) @ $0 · +5 more | EDGAR |
| 2023-01-04 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 21,772 · Tax withholding (F): 9,717 @ $113.80 · Option exercise (M): 21,772 (derivative) @ $0 | EDGAR |
| 2022-12-29 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Grant/award (A): 21,772 (derivative) @ $0 · Grant/award (A): 13,972 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 8,531 @ $0 · Gift (G): 8,531 @ $0 · Sale (S): 6,974 @ $111.44 · Sale (S): 21,378 @ $111.45 | EDGAR |
| 2022-06-09 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-04-08 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Sale (S): 42,009 @ $110.02 | EDGAR |
| 2022-03-21 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 12,304 @ $0 · Gift (G): 12,304 @ $0 · Gift (G): 5,287 @ $0 · Gift (G): 5,287 @ $0 · Gift (G): 8,169 @ $0 · Gift (G): 8,169 @ $0 · +2 more | EDGAR |
| 2022-01-24 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 5,354 @ $0 · Tax withholding (F): 2,372 @ $86.42 · Option exercise (M): 5,354 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 10,729 @ $0 · Gift (G): 10,729 @ $0 · Gift (G): 50 @ $0 · Option exercise (M): 52,570 · Grant/award (A): 32,301 @ $0 · Tax withholding (F): 37,675 @ $0 · +6 more | EDGAR |
| 2021-10-29 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 10,729 @ $7.61 · Option exercise (M): 10,729 (derivative) @ $0 | EDGAR |
| 2021-10-06 | 4 | Strongbridge Biopharma plc (SBBP) | Disposition to issuer (D): 64,258 · Disposition to issuer (D): 140,000 (derivative) | EDGAR |
| 2021-10-05 | 4 | XERIS PHARMACEUTICALS INC (XERS) | Disposition to issuer (D): 19,650 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 11,228 (derivative) · Disposition to issuer (D): 11,228 (derivative) | EDGAR |
| 2021-10-05 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 50,378 · Grant/award (A): 47,040 (derivative) · Grant/award (A): 31,360 (derivative) · Grant/award (A): 31,360 (derivative) · Grant/award (A): 19,650 (derivative) · Grant/award (A): 20,000 (derivative) · +2 more | EDGAR |
| 2021-10-05 | 4 | Strongbridge Biopharma plc (SBBP) | Tax withholding (F): 17,763 @ $2.06 | EDGAR |
| 2021-09-23 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 4,042 @ $0 · Gift (G): 4,042 @ $0 · Option exercise (M): 46,271 @ $7.61 · Sale (S): 46,271 @ $110 · Option exercise (M): 46,271 (derivative) @ $0 | EDGAR |
| 2021-07-30 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Grant/award (A): 7,257 @ $0 · Tax withholding (F): 3,215 @ $102.50 · Grant/award (A): 14,514 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 66,730 @ $0 · Gift (G): 66,730 @ $0 · Sale (S): 5,287 @ $95 · Sale (S): 54,789 @ $95.00 | EDGAR |
| 2021-06-08 | 4 | XERIS PHARMACEUTICALS INC (XERS) | Grant/award (A): 11,228 (derivative) @ $0 | EDGAR |
| 2021-05-18 | 4 | Strongbridge Biopharma plc (SBBP) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-05-17 | 4 | Strongbridge Biopharma plc (SBBP) | Tax withholding (F): 18,944 @ $2.35 | EDGAR |
| 2021-02-19 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Grant/award (A): 1,965 @ $0 · Tax withholding (F): 871 @ $87.17 · Grant/award (A): 3,931 (derivative) @ $0 · Grant/award (A): 14,512 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Gift (G): 8,679 @ $0 · Gift (G): 8,679 @ $0 · Option exercise (M): 5,353 @ $0 · Tax withholding (F): 2,372 @ $77.43 · Option exercise (M): 5,353 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 41,615 · Grant/award (A): 60,313 @ $0 · Tax withholding (F): 45,256 @ $73.28 · Grant/award (A): 27,942 (derivative) @ $0 · Option exercise (M): 12,261 (derivative) @ $0 · Option exercise (M): 17,260 (derivative) @ $0 · +1 more | EDGAR |
| 2020-12-09 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Sale (S): 36,389 @ $70.31 · Sale (S): 16,200 @ $71.52 · Sale (S): 10,489 @ $72.24 · Sale (S): 9,631 @ $70.60 · Sale (S): 31,133 @ $71.32 | EDGAR |
| 2020-10-22 | 4/A | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 13,000 @ $7.61 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2020-10-21 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 13,000 @ $7.61 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1230482 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs